InayofuataMwongozo unaofuata
EU MDR and AI Medical Devices
Jamii
MWONGOZO wa Jamii
Software as a Medical Device (SaMD) is software intended for a medical purpose that can perform that purpose without being part of a hardware medical device.
Intended use, users, and patient risk shape regulatory assessment. A product label or use of AI alone does not determine whether software is a medical device; manufacturers evaluate the specific function and applicable jurisdiction.
Software as a Medical Device refers to software intended to be used for one or more medical purposes that performs those purposes without being part of a hardware medical device. Examples may include software that analyzes medical images or supports a defined clinical decision. Software embedded in a device, software that controls hardware, and general wellness apps may follow different regulatory paths. Classification depends on intended use, claims, functionality, and the law of the market where the software is offered. FDA’s guidance on device software functions distinguishes software functions that are medical devices from those that may not be. A model’s use of machine learning does not itself establish regulatory status. The manufacturer defines intended use and users, evaluates risks, and determines whether premarket authorization or other controls apply. Changes to algorithms, data inputs, or user workflows can affect performance and may require regulatory assessment and change control. Healthcare organizations should verify the product’s labeling, authorization status, supported users and populations, compatible inputs, and limitations. Do not assume that a product authorized for one task or population is suitable for another. SaMD requires quality processes, cybersecurity, post-market monitoring, and clear instructions. This overview explains the concept but does not classify a particular product or replace regulatory advice. A supplier should document the product boundary, including any cloud services, hardware dependencies, and third-party algorithms. Users should also understand whether the output is informational or intended to influence clinical action.
Madhara makubwa na ya kila siku ya AI hutegemea ni nani anayeelewa hatari na ni nani anayeweza kuchukua hatua.
Usomaji wa umma na kitaaluma huchagiza ikiwa sera thabiti ya usalama inawezekana kisiasa.
Ufafanuzi wazi hupunguza kunasa kwa hype, PR ya maabara, na ukumbi wa michezo wa maadili usioeleweka.
Software-based medical functions will continue to evolve as models update and connect to new data sources. Regulators and standards bodies are developing approaches for lifecycle oversight and software changes. Manufacturers should maintain evidence and change controls throughout product use. Providers should confirm that deployed software matches its authorized use and continue monitoring safety and performance after implementation. Ongoing evaluation can reveal changes in performance after deployment. Maintain a process to suspend or roll back a release when evidence shows unexpected risk.
A developer documents whether software analyzes images to support diagnosis or only stores files.
A manufacturer evaluates whether a model update changes the software’s intended medical purpose.
A health system checks authorization and labeling before using a SaMD product.
A software team separates wellness features from functions that make medical claims.
Kutibu hatari iliyopo kama sci-fi huku uwezo ukichanganya.
Kuchanganya usalama wa bidhaa ya uso na upatanishi chini ya uhuru wa juu.
Inawaacha watazamaji wasio wa Kiingereza na wasio wataalamu wenye vyanzo vya ubora wa chini pekee.
Tenganisha madhara ya bidhaa, matumizi mabaya, na hasara ya udhibiti / hatari za kupotosha.
Uliza ni ushahidi gani unaweza kubadilisha maoni yako kuhusu kalenda na ukali.
Pendelea vyanzo vya msingi na tathmini thabiti kuliko madai ya uuzaji.
Tambua njia moja ya hatua: kazi, sera, ufadhili, au ujuzi - sio tu ufahamu.
Free newsletter
Three verified AI stories every weekday morning, written in plain English. Free forever, no ads.
One email each weekday. Unsubscribe in one click. We never sell or share your address.
Test yourself
Instant feedback on every answer, and a shareable certificate with a verifiable ID once you pass a course.
Support free AI education. AI Understanding is a 501(c)(3) nonprofit — no ads, no paywall, ever. Make a donation
Software as a Medical Device (SaMD) is software intended for a medical purpose that can perform that purpose without being part of a hardware medical device. Intended use, users, and patient risk shape regulatory assessment. A product label or use of AI alone does not determine whether software is a medical device; manufacturers evaluate the specific function and applicable jurisdiction.
SaMD describes an independently functioning software medical purpose.
A function without medical purpose may be assessed differently.
Lifecycle documentation ties evidence to the shipped product.
Classification depends on intended use and applicable rules.
Endelea kujifunza
Miongozo zaidi imechaguliwa kwa mada hii
InayofuataMwongozo unaofuata
EU MDR and AI Medical Devices
Jamii